Navigation Links
Pioneer in schizophrenia and ethics research receives Institute of Medicine's 2013 Sarnat Prize
Date:10/21/2013

WASHINGTON The Institute of Medicine today awarded the 2013 Rhoda and Bernard Sarnat International Prize in Mental Health to William T. Carpenter, professor of psychiatry and pharmacology at the University of Maryland School of Medicine, Baltimore. He is being recognized for his achievements in broadening the understanding of schizophrenia as well as for his research on ethics and informed consent. The Sarnat Prize, which consists of a medal and $20,000, was presented to Carpenter at IOM's annual meeting in Washington, D.C.

"Our understanding of schizophrenia and how to treat it are greatly due to the lifetime dedication of Dr. Carpenter," said IOM President Harvey V. Fineberg. "His work on mental illness research ethics and academic relations has contributed significantly to policies that have become influential in setting national standards for handling this illness."

Carpenter's research into schizophrenia has helped uncover its symptoms, courses, and causes and shaped the prevention and treatment of the illness. In the 1970s, he challenged the understanding of schizophrenia, which focused on "positive" symptoms such as hallucinations and delusions, and shifted the disease paradigm to emphasize "negative" symptoms -- for example, inexpressive faces, monotone speech, and impaired social behavior. This work spurred an initiative at the National Institute of Mental Health (NIMH) that urged more focus on negative symptoms and cognitive deficits for therapeutic intervention. The domains for the disease that are specified in the 2013 Diagnostic and Statistical Manual of Mental Disorders are based on this paradigm shift and on domains Carpenter previously identified.

When schizophrenia research was under intense scrutiny due to allegations of research ethics violations -- including lack of informed consent, medication-free research, and the use of compounds to deliberately cause psychoses -- Carpenter provided key empirical data supporting competent informed consent, established new methods for implementing and documenting informed consent, and completed critical reviews demonstrating the absence of harm in off-medication research and in pharmacological challenge studies. In addition, he published guidelines for conducting schizophrenia research safely and ethically.

As director of the Maryland Psychiatric Research Center, he transformed a facility that lacked research beds, clinics, and funding into a top-tier translational research center with the dual purpose of supporting investigative work and providing unique clinical services at no cost to patients. The center recently gained support for an initiative in pre-psychotic early detection and intervention.

Carpenter is editor-in-chief of Schizophrenia Bulletin; is author of more than 400 publications; and has served on the editorial boards of the Archives of General Psychiatry, Biological Psychiatry, Journal of Nervous and Mental Disease, Neuropsychopharmacology, Psychiatry Research, Schizophrenia Research, and Current Psychiatry Reports. He is a past president of the American College of Neuropsychopharmacology and helped establish the National Alliance for Research on Schizophrenia and Depression.

Carpenter earned his bachelor's degrees from Wofford College in Spartanburg, S.C., and his medical degree from Wake Forest University School of Medicine in Winston-Salem, N.C. He has held academic appointments at the Albert Einstein College of Medicine and the New York State Psychiatric Institute. In addition, Carpenter served as a collaborating investigator for the World Health Organization International Pilot Study of Schizophrenia, on the NIMH Intramural Research Program Board of Scientific Counselors, and as a consultant and reviewer for NIMH and the National Institutes of Health on a variety of topics. He played a key role in founding the National Alliance for Research on Schizophrenia and Depression (NARSAD), now known as the Brain and Behavior Research Foundation and has chaired its scientific program since NARSAD's inception. He was also a member of a U.S. State Department delegation whose investigation of the political misuse of psychiatry in the Soviet Union resulted in a change of laws, and he provided expert testimony in the trial of John W. Hinkley for the attempted assassination of President Ronald Reagan. Carpenter was elected to the IOM in 1998.


'/>"/>

Contact: Jennifer Walsh
news@nas.edu
202-334-2138
National Academy of Sciences
Source:Eurekalert

Related medicine news :

1. Pioneering research into rare neonatal diseases
2. Three Penn State research pioneers among first Golden Goose honorees
3. Systems biologist receives $2.5 million Pioneer Award for genome research
4. Non 12 Step Addiction Rehab Pioneer Dr. A.R. Mohammad of Inspire Malibu Announces Campaign to Raise Awareness about Underage Drinking
5. Wine Country's Salt-free Pioneer Reintroduces All-Natural Salt-free Spice Blends Online
6. SNPs associated with breast cancer risk alter binding affinity for pioneer factor FOXA1
7. Pioneering research helps to unravel the brains vision secrets
8. Renowned medical genetics pioneer to join LA BioMed faculty
9. Spanish scientists develop a pioneering technique to effectively treat mucositis
10. Society of Interventional Radiology: Pioneering specialty reaches out
11. Voluntary Groups Honoured as Sewa Pioneers Award Winners 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... CO (PRWEB) , ... December 02, 2016 , ... Advanced ... announced it has appointed Jason Bice, CPA, MBA to serve as Advanced Inc.’s Chief ... for Advanced, Inc. , Jason brings extensive financial and operational leadership experience to ...
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... ... 02, 2016 , ... Mediaplanet’s newest campaign, “Digestive Heath,” hits ... proof that attitude and determination can combine into the most remarkable achievements. Over ... holidays. This campaign will offer patients a new-found hope, by seizing the opportunity ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet is ... USA Today, which covers the innovative treatments, therapeutic technologies, and revolutionized nutrition that ... “We are prolonging life 6 years in the last 3 decades,” says Dr. ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... veterinarian diagnostic imaging systems and the first company to offer robotic imaging ... Heart at their tradeshow booth # 941 for the American Association of Equine ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... Dec. 2, 2016 Lianluo Smart Limited ... "the Company") which develops, markets and sells medical ... China and international markets, recently ... and Treatment New Progress Forum, co-hosted by the ... Province , Guangdong Provincial People,s Hospital and ...
(Date:12/2/2016)... Dec. 1, 2016 The concept of rare diseases ... given to this sector has been taking shape in ... the political aspects and initiatives related to orphan medicinal products ... the level of member states individually. Many member states in ... the space of orphan medicinal products, the result of which ...
(Date:12/2/2016)... Allergan plc (NYSE: AGN ), a ... previously announced Accelerated Share Repurchase (ASR) Program. Logo - ... ... previously announced, the Company entered into a variable tenor ASR ... repurchase $10 billion of its ordinary shares. Approximately 40.5 million ...
Breaking Medicine Technology: